Colorectal Cancer Trial, Recruiting NCT06869096 Sponsor: Nanchong Central Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06869096
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 85 years of age
  • People whose colorectal (bowel) tumor has been confirmed by CT or MRI scan and is considered removable by surgery
  • People with a general health and activity level rated as fully active or able to carry out light work (performance status score of 0 or 1)
  • People whose overall fitness for surgery is rated as good to moderate by anaesthesia standards (American Society of Anesthesiology grade I–III)

Who may not be able to join:

  • People whose cancer may have spread to other parts of the body (distant metastasis)
  • People who have had a previous abdominal (stomach area) surgery
  • People who have been diagnosed with another type of cancer in the past 5 years and have previously received radiotherapy or chemotherapy
  • People who have clear medical reasons why surgery would not be safe, such as significantly abnormal liver or kidney function, or pregnancy
  • People who have taken part in another clinical trial within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
2 July 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of participants with Surgical site infection within 30 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov